Eli Lilly (LLY) has launched its weight-loss and diabetes drug, Mounjaro (tirzepatide), in India, securing a first-mover ...

Johor is set to become Asia's largest insulin hub as India's leading biotechnology firm, Biocon Ltd, invests another RM1.1 ...

Biocon Ltd share price was up by 1.50% from the previous closing price of ₹336.35. Who are peers of Biocon Ltd? The peers of Biocon Ltd are Sun Pharmaceuticals Industries Ltd, Divis Laboratories ...

Duopharma Biotech Bhd is on track for a record-breaking profit year, with earnings anticipated to increase by over 40%.

India's Biocon has expanded its pipeline of biosimilars with a $3.3 billion deal to acquire a portfolio of drugs from Viatris, the parent of its longstanding partner Mylan, which will boost its ...

CSIR NET qualification offers careers in academia, research, government, and industry. Opportunities include PhDs, scientist roles, private-sector R&D, entrepreneurship, consulting, and competitive ...

Conclusion: Revision order issued by PCIT was quashed against Make My Trip (India) Private Limited as AO had conducted a proper inquiry before allowing the deduction of Employee Stock Option Plan ...

At any given point, someone somewhere in India is minting money by tinkering with our food, inflicting terrible human and ...

She brings over a decade of experience in private equity and technology investments. Singapore-headquartered bolttech has ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

As of 11:48:15 AM GMT+5:30. Market Open. Loading Chart for BIOCON.NS ...